Shares of Intercept Pharmaceuticals (ICPT) are up 9.30% at $216.30, after the development stage biopharmaceutical company was defended at Oppenheimer. The firm’s analysts, who have $499 price target on the name, said in a report this morning that ICPT’s recent weakness does not appear tied to any new fundamental developments ; instead, they believe the equity has been hit by broader risk-off selling.
Intercept Pharmaceuticals, currently valued at $4.62B, has a median Wall Street price target of $499.50 with a high target of $693.00. Approximately 539,221 shares have already changed hands, compared to the stock’s average daily volume of 454,852.
In the past 52 weeks, shares of the New York-based firm have traded between a low of $46.81 and a high of $497.00 with the 50-day MA and 200-day MA located at $254.53 and $256.44 levels, respectively. Additionally, shares of ICPT trade at a P/E ratio of 3.48 and have a Relative Strength Index (RSI) and MACD indicator of 40.33 and -20.50, respectively.
ICPT currently prints a one year return of about 227.13% and a year-to-date return of around 190.10%.
Baidu, Inc. (BIDU) shares jumped 4.11% Thursday, after the company’s stock was upgraded by analysts at Oppenheimer to an ‘Outperform’ rating from ‘Perform’. The firm also set its price target on the stock to $280 a share, which represents a potential upside of 31% from ticker’s current pps. Oppenheimer said it upped its rating on the name as it believes “recent market correction provides a great entry opportunity” for the company.
Baidu gained $8.45 to $214.14 in mid-day trading today. Approximately 4,196,948 shares have already changed hands, compared to the stock’s average daily volume of 3,349,320 shares.
On valuation-measures, shares of Baidu have a trailing-12 and forward P/E of 38.86 and 4.20, respectively. P/E to growth ratio is 0.94, while t-12 profit margin is 29.86%. EPS registers at $5.51. The company has a market cap of $75.02B.
On trading-measure, BIDU has a beta of 2.32 and a short float of 1.47%. In the past 52 weeks, shares of the Beijing-based Internet search services provider have traded between a low of $140.66 and a high of $231.41 with the 50-day MA and 200-day MA located at $216.93 and $189.27 levels, respectively.
BIDU currently prints a one year return of about 35.80% and a year-to-date return of around 15.66%.
Allied Healthcare Products Inc. (AHPI) shares are currently printing a large uptick, gaining 47% from the previous close.
AHPI shares recently gained $1.00 to $3.18. The stock is down more than 4.00% year-over-year and has lost roughly 5.26% year-to-date. In the past 52 weeks, shares of St. Louis, Missouri-based company have traded between a low of $1.60 and a high of $3.90.
Allied Healthcare Products has a total market cap of $25.29M.
NewLink Genetics Corporation (NLNK) is a big mover this session with its shares spiking nearly 24% on the day. The move comes on solid volume too with the issue trading 3.4M shares compared to the average volume of 539,358. The stock began trading this morning at $26.36 to currently trade up $5.69 from the prior days close of $25.44. On an intraday basis it has gotten as low as $24.66 and as high as $33.00.
In the past 52 weeks, shares of Ames, Iowa-based biopharmaceutical company have traded between a low of $16.00 and a high of $53.48. Shares are up 36.92% year-over-year and 15.58% year-to-date.